FDA on Friday said it approved Medtronic's catheter-based treatment for pediatric and adult patients with severe pulmonary valve regurgitation in the right ventricular outflow tract, which carries blood from the heart to the lungs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,